170 related articles for article (PubMed ID: 18496268)
1. The cholesterol hypothesis: questioned?
Somberg JC; Molnar J
Am J Ther; 2008; 15(3):292-5. PubMed ID: 18496268
[No Abstract] [Full Text] [Related]
2. Is it over for ezetimibe?
Robinson JG; Davidson M
Expert Rev Cardiovasc Ther; 2008 Jul; 6(6):781-3. PubMed ID: 18570614
[No Abstract] [Full Text] [Related]
3. Ezetimibe revisited.
Med Lett Drugs Ther; 2008 Aug; 50(1293):67-8. PubMed ID: 18719525
[No Abstract] [Full Text] [Related]
4. [Dual cholesterol inhibition. More high risk patients achieve LDL cholesterol values below 100 mg/dl].
MMW Fortschr Med; 2008 Jun; 150(23):39. PubMed ID: 18575369
[No Abstract] [Full Text] [Related]
5. [Combination of Zocor with Ezetrol].
Thibaut P; Sternon J
Rev Med Brux; 2006; 27(6):S526. PubMed ID: 17256422
[No Abstract] [Full Text] [Related]
6. Biomarkers and surrogate endpoints in cardiovascular therapeutics research: under scrutiny following results of the ENHANCE Study.
Pauriah M; Struthers AD; Lang CC
Cardiovasc Ther; 2008; 26(2):85-8. PubMed ID: 18485130
[No Abstract] [Full Text] [Related]
7. [The SHARP study].
Bianchi S; Gaspardone A
G Ital Cardiol (Rome); 2013 Feb; 14(2):87-91. PubMed ID: 23389310
[No Abstract] [Full Text] [Related]
8. ["The lower LDL cholesterol levels, the better" still valid. Negative/neutral conclusions of three studies on statins do not change the clinical practice].
Olsson AG; Nilsson PM
Lakartidningen; 2009 Mar 18-24; 106(12):854-7. PubMed ID: 19452786
[No Abstract] [Full Text] [Related]
9. LDL-Cholesterol is the King.
Goumas GS
Angiology; 2009; 60(3):387-8. PubMed ID: 19497926
[No Abstract] [Full Text] [Related]
10. After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe.
Mascitelli L; Ravnskov U; Pezzetta F; Goldstein MR
Angiology; 2009; 60(1):127-8; author reply 129-30. PubMed ID: 19049996
[No Abstract] [Full Text] [Related]
11. Women, the media, and heart disease. For better or for worse?
Savoie I; Kazanjian A; Brunger F
Int J Technol Assess Health Care; 1999; 15(4):729-37. PubMed ID: 10645114
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
Eichhorn EJ
N Engl J Med; 2008 Jul; 359(5):529-30; author reply 532. PubMed ID: 18677795
[No Abstract] [Full Text] [Related]
13. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
Connor WE
N Engl J Med; 2008 Jul; 359(5):530; author reply 532-3. PubMed ID: 18677797
[No Abstract] [Full Text] [Related]
14. ENHANCE: food for the ostriches.
Jackson G
Int J Clin Pract; 2008 May; 62(5):667-8. PubMed ID: 18412925
[No Abstract] [Full Text] [Related]
15. Your cholesterol might have to come down--way down.
Comarow A
US News World Rep; 2001 May; 130(21):46-8. PubMed ID: 11383131
[No Abstract] [Full Text] [Related]
16. [Commentary to the article: Kastelein JJ, Akdim F, Stroes ES, et al.; ENHANCE Investigators. Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med 2008; 358: 1431-43 ].
Michałek A
Kardiol Pol; 2008 May; 66(5):597-8, discussion 598-9. PubMed ID: 18630396
[No Abstract] [Full Text] [Related]
17. [Dual lipid control without anti-atherosclerosis effect].
Einecke D
MMW Fortschr Med; 2008 Apr; 150(16):18, 20. PubMed ID: 18557109
[No Abstract] [Full Text] [Related]
18. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
Kaye T
N Engl J Med; 2008 Jul; 359(5):531-2; author reply 532-3. PubMed ID: 18677800
[No Abstract] [Full Text] [Related]
19. After ENHANCE: the cholesterol hypothesis is alive and well.
Hamilton-Craig IR
Med J Aust; 2008 Sep; 189(6):303-4. PubMed ID: 18803531
[No Abstract] [Full Text] [Related]
20. Is there a problem with ezetimibe or just ENHANCEd hype?
Whayne TF
Angiology; 2008 Dec-2009 Jan; 59(6):661-3. PubMed ID: 18796445
[No Abstract] [Full Text] [Related]
[Next] [New Search]
